Sort by:
Results 1 - 10 of 30
... accumulate water for
extended periods of time.
Equine Herpes Myeloencephalopathy (EHM) is a disease condition
caused by Equine Herpes Virus 1 (EHV1). This virus historically
manifested with ...
Date:
November
01, 2023
... EHM)
is a disease condition caused by Equine Herpes
Virus 1 (EHV1). EHV1 typically causes respiratory
and ...
Date:
October
23, 2024
... prolonged coagulation time for blood; abnormal bleeding occurs. Herpes A general term used for a variety of ... nerve endings caused by a number of different herpes viruses. Methicillin-resistant Staphylococcus Aureus (MRSA) Infection that ...
Date:
March
16, 2022
... unacceptable toxicity include the following:
Parasitic (helminth) infection Herpes zoster infection Headache Injection site reaction Back pain ...
Description: This is the prior authorization (PA) criteria for coverage of this drug under Minnesota Health Care Programs (MHCP).
Date:
February
09, 2018
... unacceptable toxicity include the following:
Parasitic (helminth) infection Herpes zoster infection Treatment has resulted in clinical improvement ...
Description: This is the prior authorization (PA) criteria for coverage of this drug under Minnesota Health Care Programs (MHCP).
Date:
July
03, 2018
... unacceptable toxicity include the following:
Parasitic (helminth) infection Herpes zoster infection Treatment has resulted in clinical improvement ...
Description: This is the prior authorization (PA) criteria for coverage of this drug under Minnesota Health Care Programs (MHCP).
Date:
February
09, 2018
... the cornea and conjunctiva (e.g., active epithelial herpes simplex keratitis [dendritic keratitis], vaccinia, varicella), OR Mycobacterial ...
Description: This is the prior authorization (PA) criteria for coverage of this drug under Minnesota Health Care Programs (MHCP).
Date:
December
27, 2019
... other opportunistic infections), tuberculosis, virus reactivation (e.g., herpes zoster, Hepatitis B, Hepatitis C), malignancy and lymphoproliferative ...
Description: This is the prior authorization (PA) criteria for coverage of this drug under Minnesota Health Care Programs (MHCP).
Date:
March
06, 2025
... spch as toxoplasmosis,
ruoeUa; cytoiJj'eSalic inclUSion disease,
herpe ~anciepb~litis,
aitcl other serious
infec\!Qus procesaes ... robelJa
8~drome.:cyt~megalic
inclusion
disease, and herpes
encep~alitis.
•
•
965-115~'
..
[FR Doc, 00-28745 ...
Date:
June
12, 2008
... the liver, spleen or lymph nodes; or
2. Herpes simplex virus causing 1 of the following:
a. ... or encephalitis); or
c. Disseminated infection; or
3. Herpes zoster, either disseminated or with multidermatomal eruptions resistant ...
Date:
August
30, 2010